HAVLF

HAVN Life Sciences Inc.

OTC Markets OTCPKUSDEQUITY DELAYED

0.00

■ 0.00 (0.00%)

MARKET · —

Price

Open

—

Prev close

0.00

Day high

0.01

Day low

0.01

Volume

22.11K

Market cap

—

P/E (TTM)

—

52W range

— – 0.01

Options chain

Account required

ExpirySpot 0.00

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Trailing performance

Price return · vs SPY

Returnvs SPY

0.00% +1.4%

0.00% -3.7%

0.00% -3.1%

0.00% -11.1%

YTD

0.00% -12.3%

-90.00% -110.0%

-99.20% -173.4%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Financial statements

As reported · 1 year

Blank means not reported, not zero

Line item	2022	YoY
Total revenue	$276.47K
Operating revenue	$276.47K
Cost of revenue	$186.78K
Gross profit	$89.69K
Research & development	$655.80K
Selling, general & admin	$8.67M
Total operating expense	$9.90M
Operating income	-$9.81M
Net interest income	-$34.14K
Pre-tax income	-$22.44M
Net income	-$22.44M
Net income to common	-$22.44M
Basic EPS	-5.25
Diluted EPS	-5.25
EBIT	-$22.38M
EBITDA	-$21.80M
Basic shares	4.28M
Diluted shares	4.28M

Line item

2022

YoY

Total revenue

$276.47K

Operating revenue

$276.47K

Cost of revenue

$186.78K

Gross profit

$89.69K

Research & development

$655.80K

Selling, general & admin

$8.67M

Total operating expense

$9.90M

Operating income

-$9.81M

Net interest income

-$34.14K

Pre-tax income

-$22.44M

Net income

-$22.44M

Net income to common

-$22.44M

Basic EPS

-5.25

Diluted EPS

-5.25

EBIT

-$22.38M

EBITDA

-$21.80M

Basic shares

4.28M

Diluted shares

4.28M

Line item	2022	YoY
Cash & equivalents	$1.06M
Cash & short-term investments	$1.06M
Accounts receivable	$151.25K
Inventory	$1.15M
Total current assets	$2.75M
Property, plant & equipment	$356.38K
Goodwill & intangibles	$934.03K
Total assets	$4.06M
Total current liabilities	$608.27K
Total debt	$389.35K
Total liabilities	$918.46K
Retained earnings	-$52.86M
Shareholder equity	$3.14M
Working capital	$2.14M
Net tangible assets	$2.21M
Shares issued	5.09M

Line item

2022

YoY

Cash & equivalents

$1.06M

Cash & short-term investments

$1.06M

Accounts receivable

$151.25K

Inventory

$1.15M

Total current assets

$2.75M

Property, plant & equipment

$356.38K

Goodwill & intangibles

$934.03K

Total assets

$4.06M

Total current liabilities

$608.27K

Total debt

$389.35K

Total liabilities

$918.46K

Retained earnings

-$52.86M

Shareholder equity

$3.14M

Working capital

$2.14M

Net tangible assets

$2.21M

Shares issued

5.09M

Line item	2022	YoY
Net income	-$22.44M
Depreciation & amortisation	$575.62K
Stock-based compensation	$1.79M
Change in working capital	-$536.20K
Operating cash flow	-$7.88M
Capital expenditure	-$103.07K
Investing cash flow	-$2.03M
Financing cash flow	$1.56M
Free cash flow	-$7.98M
End cash position	$1.06M

Line item

2022

YoY

Net income

-$22.44M

Depreciation & amortisation

$575.62K

Stock-based compensation

$1.79M

Change in working capital

-$536.20K

Operating cash flow

-$7.88M

Capital expenditure

-$103.07K

Investing cash flow

-$2.03M

Financing cash flow

$1.56M

Free cash flow

-$7.98M

End cash position

$1.06M

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.00

+0.00% from price

SMA 20

0.00

0.00% from price

SMA 50

0.00

0.00% from price

SMA 100

0.00

+0.00% from price

SMA 200

0.00

-62.16% from price

EMA 12

0.00

+0.00% from price

EMA 26

0.00

-0.00% from price

EMA 50

0.00

-1.23% from price

RSI (14)

37.8

Neutral

MACD (12,26,9)

-0.00

Hist 0.00

ATR (14)

0.00

—

Realised vol 30D

0.0%

Annualised

Bollinger upper

0.00

20, 2σ

Bollinger lower

0.00

20, 2σ

50 / 200 cross

Death

0.00 vs 0.00

Trend bias

Below 200

-62.16%

Risk profile

Daily returns · 1Y window

Beta vs SPY

-136.75

Less volatile than market

Correlation to SPY

-0.09

Largely independent

Realised vol 30D

0.0%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-99.5%

Peak to trough

Max drawdown 5Y

-100.0%

Peak to trough

ATR 14

0.00

Average true range

Beta (reported)

—

5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.